Related references
Note: Only part of the references are listed.Asymptomatic Malaria Infection and the Immune Response to the 2-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen in Adults and Children
D. Ishola et al.
CLINICAL INFECTIOUS DISEASES (2022)
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
David Ishola et al.
LANCET INFECTIOUS DISEASES (2022)
Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols
Frank Baiden et al.
PLoS One (2022)
Ebola Virus Glycoprotein IgG Seroprevalence in Community Previously Affected by Ebola, Sierra Leone
Daniela Manno et al.
EMERGING INFECTIOUS DISEASES (2022)
Baseline Asymptomatic Malaria Infection and Immunogenicity of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine: The Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE)
Barbara E. Mahon et al.
JOURNAL OF INFECTIOUS DISEASES (2021)
Serologic Markers of Previous Malaria Exposure and Functional Antibodies Inhibiting Parasite Growth Are Associated With Parasite Kinetics Following a Plasmodium falciparum Controlled Human Infection
Jane Achan et al.
CLINICAL INFECTIOUS DISEASES (2020)
Ebola virus vaccine receives prequalification
Talha Burki
LANCET (2019)
Impacts of environmental and socio-economic factors on emergence and epidemic potential of Ebola in Africa
David W. Redding et al.
NATURE COMMUNICATIONS (2019)
The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts
Massinissa Si Mehand et al.
ANTIVIRAL RESEARCH (2018)
Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)
Ana Maria Henao-Restrepo et al.
LANCET (2017)
Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial
Ana Maria Henao-Restrepo et al.
LANCET (2015)
Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities
Danica A. Helb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Immunogenicity to the bivalent HPV-16/18 vaccine among adolescent African students exposed to helminths and malaria
Miriam Nakalembe et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2015)
Malaria-associated atypical memory B cells exhibit markedly reduced B cell receptor signaling and effector function
Silvia Portugal et al.
ELIFE (2015)
Effect of fever on the serum antibody response of Gambian children to Haemophilus influenzae type b conjugate vaccine
S Usen et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Share Paper
